Loading…
CIK 0001844645 • 6 13F filings • May 14, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("pivotal-bioventure-partners-investment-advisor-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC | COM | $31.9M | 11.4%Prev: 26.8% | 1,355,892 SH | Decreased-764,616 SH |
| AVALO THERAPEUTICS INC | COM NEW | $4.4M | 1.6% | 295,933 SH | New |
| BIOAGE LABS INC | COM | $11.4M | 4.1%Prev: 2.0% | 653,374 SH | Increased |
| BOLT BIOTHERAPEUTICS INC | COM NEW | $172K | 0.1% | 42,581 SH | New |
| EVOMMUNE INC | COM SHS | $44.3M | 15.8% | 1,926,943 SH | New |
| IMMUNOME INC | COM | $16.0M | 5.7% | 732,512 SH | New |
| MAPLIGHT THERAPEUTICS INC | COM | $12.4M | 4.4% | 611,447 SH | New |
| OCULIS HOLDING AG | ORDINARY SHARES | $44.7M | 16.0%Prev: 35.4% | 1,680,283 SH | Increased-620,491 SH |
| RALLYBIO CORP | COM | $2.7M | 1.0%Prev: 1.3% | 300,579 SH | Increased-2,104,065 SH |
| RECURSION PHARMACEUTICALS IN | CL A | $1.8M | 0.7%Prev: 2.5% | 595,518 SH | Decreased |
| TREVI THERAPEUTICS INC | COM | $18.5M | 6.6% | 1,553,726 SH | New |
| VAXCYTE INC | COM | $79.8M | 28.5%Prev: 21.7% | 1,372,425 SH | Increased+661,691 SH |
| ZENAS BIOPHARMA INC | COM | $11.6M | 4.1%Prev: 4.7% | 591,991 SH | Increased-144,654 SH |
| Q2 2026 |
| 13F-HR |
| 0001012975-26-000759 |
| $307.8M |
| View |
| Aug 13, 2025 | Q2 2025 | 13F-HR | 0001012975-25-000438 | $161.3M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0001012975-26-000421 | $279.8M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001012975-25-000233 | $123.6M | View |